On Oct. 24, blockchain security firm PeckShield reported that addresses linked to the Radiant Capital exploiter have bridged “nearly all” of the ill-gotten crypto from the exploit from layer-2 ...

(Image Credits: Pixabay) Alembic Pharmaceuticals Limited on Monday announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...

Ebitda grew 13.7 per cent, and margins expanded to 16.4 per cent. Alembic Pharmaceuticals: The company has received final approval from the US FDA for its abbreviated new drug application (ANDA) for ...

Alembic Pharmaceuticals Limited has secured final approval from the US Food and Drug Administration (USFDA) for its Diltiazem Hydrochloride Extended-Release Capsules USP in strengths of 120 mg, 180 mg ...

NEW DELHI, Oct 21: Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic version of Diltiazem Hydrochloride extended-release capsules ...

Alembic has received the Food and Drug Administration’s permission for alcaftadine ophthalmic solution, 0.25% (OTC), which is the generic of AbbVie’s Lastacaft. Alcaftadine ophthalmic solution ...

Note that this action makes certain assumptions about the structure of Alembic revision files. It is unlikely that Alembic will change this (if ever), but making a note of that here regardless. Lastly ...